Clinical and Translational Research
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7242-7255
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7242
Figure 1
Figure 1 Expression of hepatocyte nuclear factor 4 alpha in gastric cancer tissues and para-cancerous tissues. A, B: Representative figures of hepatocyte nuclear factor 4 alpha (HNF4α) expression (nuclear staining) at different grades of pathological scores in gastric cancer tissues (GC) (A) and para-cancerous (PC) tissues (B); C: Numbers of samples expressing HNF4α in GC and PC groups. Specimens were examined under a light microscope (200 × magnification). HNF4: Hepatocyte nuclear factor 4 alpha.
Figure 2
Figure 2 Expression of wingless-related integration site in gastric cancer tissues and para-cancerous tissues. A, B: Representative figures of wingless-related integration site (WNT5a) expression (cytoplasmic staining) at different grades of pathological scores in gastric cancer tissues (GC) (A) and para-cancerous (PC) tissues (B); C: Numbers of samples expressing WNT5a in GC and PC groups. Specimens were examined under a light microscope (200 × magnification). WNT5a: Wingless-related integration site.
Figure 3
Figure 3 Expression of β-catenin in gastric cancer tissues and para-cancerous tissues. A, B: Representative figures of β-catenin expression (membranous and cytoplasmic staining) at different grades of pathological scores in gastric cancer (GC) (A) and para-cancerous (PC) tissues (B); C: Numbers of samples expressing β-catenin in GC and PC groups. Specimens were examined under a light microscope (200 × magnification).